Pulmonary nodules
Conditions
Interventions
Sponsors
Beijing Hospital of TCM,Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The imaging performance shows that there is at least one measurable lung nodule, which meets the following conditions: ? The average diameter of solid component of solid nodule or part of solid nodules is =6.0mm and < 15.0mm, or the average diameter of non-solid nodules is =8.0mm and < 15.0 mm; Or ? The average diameter of solid nodules, solid components of partial solid nodules or non-solid nodules is = 15.0 mm. (2) The time for initial discovery of lung nodules is less than three months, which can provide chest CT examination results; (3) Aged 18–74 years old, no gender limitation; (4) The main syndromes in TCM are deficiency of lung and spleen, and mutual accumulation of phlegm and blood stasis. (5) Patients who complained of pulmonary nodules and required traditional Chinese medicine treatment, agreed to participate in this study and signed the informed consent form, and were able to receive the treatment and follow-up observation as planned, with good compliance.
Exclusion criteria
Exclusion criteria: (1) Patients with confirmed sarcoidosis and infectious diseases caused by known pathogens; (2) A history of previous malignant tumors, with or without the exception of recurrence or metastasis confirmed by clinical or pathological diagnosis; (3) Those who, after collective consultation by multidisciplinary physicians, were highly suspected to be malignant and suitable for surgical treatment; (4) No reexamination after anti-inflammatory treatment; (5) Patients taking glucocorticoids or other immunosuppressive agents in the past one month; (6) Patients with severe primary diseases or tumor diseases such as cardiovascular and cerebrovascular diseases, liver, kidney, and blood; (7) Accompanied with mental diseases such as mania, schizophrenia and other reasons, unable to cooperate with observation and research; (8) Planned pregnancy, pregnant or lactating women; (9) Allergies to known investigational drugs; (10) Clinical trials of other drugs are ongoing; (11) Analysis of the impact of missing case information on data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary nodule volume;Mean diameter of pulmonary nodules;Mean diameter of pulmonary nodules;Pulmonary nodule site;Pulmonary nodule density;Morphology of pulmonary nodules; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional chinese medicine syndrome scoring;Mental condition;Serum tumor markers; | — |
Countries
CHINA
Contacts
Public ContactYU Ming-wei
Beijing Hospital of TCM,Capital Medical University
Outcome results
None listed